HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Laure Favot Selected Research

Psoriasis (Pustulosis Palmaris et Plantaris)

12/2017Characterization of skin Th17 transcriptional profiles in psoriatic patients under adalimumab biotherapy.
1/2017Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
1/2016Oncostatin M overexpression induces skin inflammation but is not required in the mouse model of imiquimod-induced psoriasis-like inflammation.
10/2015IMQ-induced skin inflammation in mice is dependent on IL-1R1 and MyD88 signaling but independent of the NLRP3 inflammasome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Laure Favot Research Topics

Disease

8Inflammation (Inflammations)
06/2022 - 09/2009
5Neoplasms (Cancer)
11/2020 - 02/2003
4Psoriasis (Pustulosis Palmaris et Plantaris)
12/2017 - 10/2015
2Fibrosis (Cirrhosis)
06/2022 - 01/2019
2Rhinosinusitis
06/2022 - 12/2021
2Nasal Polyps (Nasal Polyp)
06/2022 - 12/2021
2Hyperplasia
11/2018 - 12/2017
2Atherosclerosis
08/2003 - 02/2003
1Polyps
12/2021
1Colorectal Neoplasms (Colorectal Cancer)
11/2020
1Exanthema (Rash)
11/2020
1Cicatrix (Scar)
01/2019
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2018
1Fatty Liver
01/2016
1Erythema
01/2016
1Dermatitis
01/2016
1Skin Diseases (Skin Disease)
10/2015
1Carcinogenesis
01/2015
1Melanoma (Melanoma, Malignant)
01/2015
1Leg Ulcer
03/2013
1Ulcer
03/2013
1Necrosis
02/2011
1Mevalonate Kinase Deficiency
09/2009
1Pathologic Neovascularization
09/2004

Drug/Important Bio-Agent (IBA)

10CytokinesIBA
12/2021 - 09/2009
5Oncostatin MIBA
06/2022 - 03/2013
3Interleukin-6 (Interleukin 6)IBA
11/2018 - 03/2013
3Imiquimod (Aldara)FDA LinkGeneric
01/2017 - 01/2016
3Interleukin-1 (Interleukin 1)IBA
10/2015 - 09/2009
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2015 - 08/2003
2Proteins (Proteins, Gene)FDA Link
06/2022 - 10/2015
2Interleukin-4 (Interleukin 4)IBA
06/2022 - 11/2020
2Monoclonal AntibodiesIBA
11/2020 - 12/2017
2Interleukin-17 (Interleukin 17)IBA
01/2017 - 01/2016
2delphinidinIBA
01/2015 - 02/2003
1Interleukin-8 (Interleukin 8)IBA
11/2020
1Cetuximab (Erbitux)FDA Link
11/2020
1ErbB Receptors (EGF Receptor)IBA
11/2020
1Interleukin-23 (Interleukin 23)IBA
11/2020
1Adalimumab (Humira)FDA Link
12/2017
1Interleukin-22 (IL-22)IBA
01/2017
1Serum Amyloid A Protein (Serum Amyloid A)IBA
01/2017
1AntibodiesIBA
01/2016
1InflammasomesIBA
10/2015
1Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
10/2015
1Thalidomide (Thalomid)FDA Link
02/2011
1InterleukinsIBA
02/2011
1Lenalidomide (CC 5013)FDA Link
02/2011
1Simvastatin (Zocor)FDA LinkGeneric
09/2009
1Mevalonic Acid (Mevalonate)IBA
09/2009
1Terpenes (Terpenoids)IBA
09/2009

Therapy/Procedure

2Intradermal Injections
01/2016 - 01/2016
1Therapeutics
11/2020